123 related articles for article (PubMed ID: 3329719)
1. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.
Colletta G; Cirafici AM; Consiglio E; Vecchio G
Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719
[TBL] [Abstract][Full Text] [Related]
2. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
3. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line.
Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A
Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619
[TBL] [Abstract][Full Text] [Related]
4. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
Baptist M; Dumont JE; Roger PP
Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
[TBL] [Abstract][Full Text] [Related]
5. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture.
Isozaki O; Kohn LD
Mol Endocrinol; 1987 Nov; 1(11):839-48. PubMed ID: 2856403
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
7. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
8. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
Carbone A; Gusella GL; Radzioch D; Varesio L
Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
[TBL] [Abstract][Full Text] [Related]
9. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
Cao W; Li F; Steinberg RH; LaVail MM
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
11. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
Kohl NE; Ruley HE
Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
[TBL] [Abstract][Full Text] [Related]
12. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
[TBL] [Abstract][Full Text] [Related]
13. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of transcription of c-myc and c-fos proto-oncogenes by 12-O-tetradecanoylphorbol-13-acetate in mortal and immortal human urothelial cells.
Skouv J; Christensen B; Autrup H
J Cell Biochem; 1987 Jun; 34(2):71-9. PubMed ID: 3597558
[TBL] [Abstract][Full Text] [Related]
15. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells.
Ronai ZA; Okin E; Weinstein IB
Oncogene; 1988 Feb; 2(2):201-4. PubMed ID: 3285298
[TBL] [Abstract][Full Text] [Related]
17. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
Curran T; Bravo R; Müller R
Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
[TBL] [Abstract][Full Text] [Related]
18. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
19. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
[TBL] [Abstract][Full Text] [Related]
20. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]